SmartPath to dStream for XR and 3.0T. Model (REF) Numbers 781270, 782113, 782129.

FDA Device Recall #Z-0956-2024 — Class II — January 3, 2024

Recall Summary

Recall Number Z-0956-2024
Classification Class II — Moderate risk
Date Initiated January 3, 2024
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Philips North America
Location Cambridge, MA
Product Type Devices
Quantity 21 US; 265 OUS

Product Description

SmartPath to dStream for XR and 3.0T. Model (REF) Numbers 781270, 782113, 782129.

Reason for Recall

The Quadrature Body Coil (QBC) seal adhesive may fail, creating sharp edges that may come in contact with patients. If the QBC seal becomes loose during the scanning process, the risk to the patient may include skin abrasions, bruises, lacerations, hair loss/entanglement, and tissue injury.

Distribution Pattern

Worldwide - US Nationwide distribution.

Lot / Code Information

a. Model No. 781270; UDI-DI 00884838095083. b. Model No. 782113; UDI-DI 00884838098909. c. Model No. 782129; UDI-DI 00884838105805. All units affected

Other Recalls from Philips North America

Recall # Classification Product Date
Z-1156-2026 Class II Patient Information Center iX; Software Versio... Dec 22, 2025
Z-1204-2026 Class II Evolution Upgrade 1.5T. Product Codes (REF): ... Dec 3, 2025
Z-1215-2026 Class II SmartPath to dStream for 3.0T. Product Code (... Dec 3, 2025
Z-1207-2026 Class II Ingenia 3.0T. Product Code (REF): (1) 781342,... Dec 3, 2025
Z-1209-2026 Class II Ingenia Ambition S. Product Code (REF): 78210... Dec 3, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.